3 HUGE STATEMENTS IN PR THAT ARE NOW FACT
Fact 1: We will be current very soon and we will have a GMP certified manufacturer in the near future...HUGE...Seriously guys...why do you think they gave an update...
"Enzolytics anticipates a response on the application recently made at OTC Markets in the coming week and will begin bringing their filings current, immediately upon membership. In addition, management of ENZC is scheduling a meeting with a GMP manufacturer before the end of the month."
Fact 2: NIH/NSF applications will get approved. The NIH and NSF NEED THEM as stated in the below excerpt as they have tried for years to get ENZC's results. UNBELIEVABLE!!
"...we have applications pending with the National Institute of Health (NIH) and the National Science Foundation (NSF) for further development of our anti-HIV monoclonal antibodies and our proposed production of anti-SARS-CoV-2 (Coronavirus) antibodies. These applications are being reviewed now."
AND THE KICKER IS...
"Recall that others, including the NIH in conjunction with Vaccine Research Center attempted for years to produce monoclonal antibodies against HIV and failed because of "virus escape" - a euphonism for the fact that their antibodies targeted a site that mutates allowing the virus to "escape" over time."
Fact 3: BioClonetics and ENZC have technology, product and methodology differentiation from EVERY OTHER MAJOR PHARMA AND 15 YEARS ON THE PATENT. Meaning...no one else can manufacture this drug for the next 15 years.
"We do however note the procedure used by other pharma companies for producing these antibodies differs significantly from ours. Other pharma companies produce "humanized" rat and mouse monoclonal antibodies where the original antibody affinity and specificity are not maintained and the chances of immunogenicity are increased. Our methodology also differs significantly from other pharma approaches using the transgenic mouse model [a human immune system which has been "grafted" within a mouse model] having been "vaccinated" with specific and selected purified Coronavirus proteins."
AND LASTLY WE HAVE BEEN SOCIALIZING WITH THE BIG BOYS, THEY KNOW WHAT WE HAVE:
When we recently asked Eli Lilly for the identity of the binding sites for its anti-Coronavirus monoclonal antibodies, they were unable to share that information with us. The fact is that multiple neutralizing antibodies will be necessary to control the Coronavirus, just as is the case with HIV. Our program is to produce multiple antibodies each targeting conserved, immutable sites on the virus.
THE WRITING IS ON THE WALL. SO MUCH MORE TO COME. ENZC IS THE REAL DEAL
Just my .02
CPM
P.S. Again, only allowed 1 post a day as the "Clown Posse" doesn't want my positive opinion to be heard.
